ISSN: 1478-6354

Journal Home

Arthritis Research and Therapy Q1 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Arthritis Research and Therapy is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 150. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1925 €. The scope of the journal is focused on arthritis, musculoskeletal conditions, rheumatic conditions. It has an SJR impact factor of 1,788 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,788.

Arthritis Research and Therapy focuses its scope in these topics and keywords: rheumatoid, patients, systemic, lupus, arthritis, osteoarthritis, erythematosus, eotaxin, early, dna, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Immunology and Allergy (Q1) Immunology and Allergy (Q1) Rheumatology (Q1) Immunology (Q2)

Price

1925 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,788

SJR Impact factor

150

H Index

282

Total Docs (Last Year)

860

Total Docs (3 years)

10557

Total Refs

4066

Total Cites (3 years)

825

Citable Docs (3 years)

4,23

Cites/Doc (2 years)

37,44

Ref/Doc

Other journals with similar parameters

Clinical Microbiology Reviews Q1
Nature Immunology Q1
Science immunology Q1
Molecular Systems Biology Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Spondyloarthritides: evolving therapies

Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjogren's syndrome

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy

All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation

Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis

Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and ROR gammat in gammad T cells

7th meeting of the global arthritis research network

Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial

Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients

Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study

Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats

SHOW MORE ARTICLES

Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases -a longitudinal study

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor

Association between occupation and knee and hip replacement due to osteoarthritis: a case-control study

Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study

Antiphospholipid syndrome

Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments

Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity

The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis

Challenges in understanding Sjogren's syndrome - improved insights into the pathogenesis generate hope for innovative therapies?

Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis

Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .